News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sumanta K. Pal: We have extended our abstract submission deadline for SoCalGU25
Sumanta K. Pal/ cityofhope.org
Feb 9, 2025, 06:44

Sumanta K. Pal: We have extended our abstract submission deadline for SoCalGU25

Sumanta K. Pal, Medical Oncologist at City of Hope, shared a post on LinkedIn:

“We have extended our abstract submission deadline to February 13 for SoCalGU25! Looking forward to a terrific meeting bringing together all Southern California investigators interested in GU malignancies. Investigators, please pass on the abstract deadline to your residents and fellows!”

 

cancer OncoDaily Oncology Sumanta K. Pal
Special Coverage
Blog Posts
Aug 12, 2025, 14:45
New Genome BC-funded Projects on Genetic Testing for Hereditary Cancer
Voices
Aug 12, 2025, 14:45
Nirmala Bhoo Pathy: Talking About Cancer Costs and Women’s Health at MBCS 2025
Voices
Aug 12, 2025, 14:40
The Launch of BrightSeq - Dana-Farber Cancer Institute
Voices
Aug 12, 2025, 14:32
Herbert Loong: The Global Sarcoma Community Is One Big Family
Voices
Aug 12, 2025, 14:13
Biobanking is a Crucial Component of Research
Voices
Aug 12, 2025, 13:44
Ramy Sedhom: Why Should Precision Palliative Care Match Precision Oncology?
Career Updates
Aug 12, 2025, 13:27
Daniel Frigo: Congrats to Pham Hong Anh "Nikki" Cao on Her Newly Awarded F99 Fellowship
Opinion
Aug 12, 2025, 13:21
Web-Based Tool to Reduce Lung Cancer Mortality Rates and Advance Treatment
Voices
Aug 12, 2025, 13:00
Vahe Grigoryan: Truly Meaningful Experience
Societies
Aug 12, 2025, 12:34
Guillermo Chantada: ESO-SIOPE Masterclass in Paediatric Oncology
Insight
Aug 12, 2025, 12:34
May Daher: The Promise of iPSC-derived CAR-NK Cells for Autoimmune Disease
Radiotherapy
Aug 12, 2025, 12:21
New RT Paper Alert: Proton Therapy Benefits IDH-Mutant Glioma Patients